EGFR and neoplasm: Like other oncogenic mutations, EGFR mutations display “clonal” behaviour in vivo: they arise within individual cells which propagate and diverge into different lineages which undergo a quasi-Darwinian process where tumour cell populations descended from a progenitor or ‘clone” acquire successive somatic mutations that confer a selective advantage (11).